CN104825604A - Compound traditional Chinese medicine preparation for treating qi stagnation and blood stasis type chronic prostatitis - Google Patents
Compound traditional Chinese medicine preparation for treating qi stagnation and blood stasis type chronic prostatitis Download PDFInfo
- Publication number
- CN104825604A CN104825604A CN201510200623.8A CN201510200623A CN104825604A CN 104825604 A CN104825604 A CN 104825604A CN 201510200623 A CN201510200623 A CN 201510200623A CN 104825604 A CN104825604 A CN 104825604A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood stasis
- radix
- stagnation
- chronic prostatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention creation discloses a compound traditional Chinese medicine preparation for treating qi stagnation and blood stasis type chronic prostatitis; the compound traditional Chinese medicine preparation comprises the following raw material medicines in parts by weight: 10-30 parts of salvia miltiorrhiza, 10-25 parts of cowherb seed, 15-30 parts of red paeony root, 3-15 parts of liquorice, 5-20 parts of pericarpium citri reticulatae viride, 5-20 parts of rhizoma corydalis, 5-30 parts of raw radix astragalis, 1-8 parts of centipede, 3-15 parts of leech, 5-20 parts of cyathula root, and 5-20 parts of ligusticum chuanxiong. The preparation has an obvious medicinal effect, has non-toxic side effect, is free of decoction, convenient to take and capable of promoting blood circulation to remove blood stasis, can effectively and safely treat chronic prostatitis, has significant effects on improving the patient life quality and preventing the recurrence, and is worthy of popularization and application.
Description
Technical field
The invention belongs to biomedicine field, particularly relate to a kind of Chinese traditional compound medicine for the treatment of qi stagnation and blood stasis type chronic prostatitis.
Background technology
Chronic prostatitis (CP) is the modal genito-urinary system benign disease of adult male, and sickness rate is high, the male of 35% ~ 50% in life certain time can be subject to prostatitic impact.CP disease is complicated, the course of disease is touching, treats more thorny.Bring serious psychological burden and financial burden to patient, have a strong impact on the quality of life of patient, the anxiety and depression emotion that even therefore sick generation is serious, and then cause many social problems.Various countries andropathy scholar has now been caused to pay close attention to the attention with countries in the world greatly.
There is no prostatitic name of disease in Chinese medical book, generally belong to " stranguria ", " essence is turbid ", " excessive in vain ", " nebulousurine " category according to the urethral symptom of CNP.By prostatitis called after " essence is turbid " in " Chinese medical disease Standardization of diagnosis and curative effect ".Through a large amount of clinical research, most scholar thinks, blood stasis is the core pathogenesis of primary disease, and qi depression to blood stasis runs through disease all the time, treats based on blood circulation promoting and blood stasis dispelling, holds concurrently with the kidney invigorating, heat clearing away.
Under the leading that my section is taught at Li Haisong, carry out more than 20 years of research work around chronic prostatitis, obtain successional achievement from aspects such as epidemiological study, randomized clinical control study, theoretic discussions.To 918 routine chronic prostatitis TCM Syndrome Type distribution research displays, in all pattern of syndrome of chronic prostatitis, syndrome of qi stagnation and blood stasis is maximum, accounts for 89.76%.So we have proposed CNP " treat from blood stasis ".And declared national Eleventh Five-Year Plan science and technology supporting project problem, confirm effectiveness and the safety of activating blood and resolving stasis and treating chronic prostatitis syndrome of qi stagnation and blood stasis.
Summary of the invention
The object of the present invention is to provide a kind of Chinese traditional compound medicine for the treatment of qi stagnation and blood stasis type chronic prostatitis, blood circulation promoting and blood stasis dispelling, effectively and safely can treat chronic prostatitis.
For achieving the above object, the technical solution used in the present invention is:
A kind of Chinese traditional compound medicine for the treatment of qi stagnation and blood stasis type chronic prostatitis, with weight parts, comprise the crude drug of following component: Radix Salviae Miltiorrhizae 10-30 part, Semen Vaccariae 10-25 part, Radix Paeoniae Rubra 15-30 part, Radix Glycyrrhizae 3-15 part, Pericarpium Citri Reticulatae Viride 5-20 part, Rhizoma Corydalis 5-20 part, Radix Astragali 5-30 part, Scolopendra 1-8 part, Hirudo 3-15 part, Radix Cyathulae 5-20 part, Rhizoma Chuanxiong 5-20 part.
Further, described Chinese traditional compound medicine formula, with weight parts, comprises the crude drug of following component: Radix Salviae Miltiorrhizae 20 parts, Semen Vaccariae 15 parts, Radix Paeoniae Rubra 20 parts, 6 parts, Radix Glycyrrhizae, 10 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Corydalis 10 parts, Radix Astragali 20 parts, Scolopendra 3 parts, Hirudo 6 parts, Radix Cyathulae 10 parts, Rhizoma Chuanxiong 12 parts.
Further, described herbal mixture dosage form is granule, tablet, pill, powder.
Further, described herbal mixture dosage form is granule.
Further, described Chinese traditional compound medicine contains edible or pharmaceutic adjuvant.
Further, described adjuvant is diluent, suspending agent, antioxidant, emulsifying agent, disintegrating agent, adhesive and antiseptic.
Below the Chinese crude drug that the present invention relates to is described below:
Radix Salviae Miltiorrhizae: another name Arisaema balansae Engl., Radix Campylotropis Hirtella (Herba Myrsines Africanae), Herba Wedeliae Wallichii root, blood mountain root, RADIX SALVIAE MILTIORRHIZAE, Radix Salviae Miltiorrhizae, derive from the dry root and rhizome of labiate Radix Salviae Miltiorrhizae.There is stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, the effect of the relieving restlessness that clears away heart-fire.Cure mainly menoxenia, amenorrhea dysmenorrhea, lump in the abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia; Hepatosplenomegaly, angina pectoris.
Semen Vaccariae: call SEMEN VACCARIAE, milk rice, king bull, Fructus Hordei Vulgaris cattle, do not stay row, derive from the dry mature seed of pinkwort Vaccaria segetalis, there is promoting blood circulation to restore menstrual flow, effect of stimulating milk secretion detumescence.Cure mainly agalactia, amenorrhea, dysmenorrhea, acute mastitis swells and ache.
Radix Paeoniae Rubra: another name mountain Radix Paeoniae, Paeonia obovata Maxim., derive from the dry root of ranunculaceae plant Radix Paeoniae or river Radix Paeoniae Rubra.There is clearing away heat and cooling blood, effect of eliminating stasis to stop pain.Cure mainly maculae caused by violent heat pathogen, hematemesis and epistaxis, conjunctival congestion and swelling pain, hypochondriac pain due to stagnation of liverQI, amenorrhea dysmenorrhea, lump in the abdomen is suffered from abdominal pain, injury from falling down, carbuncle skin infection.
Radix Glycyrrhizae: another name Herba Hedyotis cantonensis root, Radix Glycyrrhizae, Radix Glycyrrhizae, Radix Glycyrrhizae, derive from the Root and Rootstock into pulse family glycyrrhiza genus Radix Glycyrrhizae.There is heat-clearing and toxic substances removing, nourishing the lung to arrest cough, coordinating the actions of various ingredients in a prescription; Effect of Radix Glycyrrhizae Preparata energy invigorating the spleen and replenishing QI.Cure mainly laryngopharynx swelling and pain, cough, weakness of the spleen and stomach, taste-blindness rate, hepatitis, hysteria, carbuncle furuncle and phyma poison, medicine and alimentary toxicosis.
Pericarpium Citri Reticulatae Viride: another name Sihuaqingpi, FTUCTUS CITRI IMMATURI, Pericarpium Citri Reticulatae Viride, derive from the dry young fruit of rutaceae orange and variety thereof or the peel of immature fruit, have soothing the liver dispelling the stagnated QI, effect that removing food stagnancyization is stagnant.Cure mainly distending pain in the chest and hypochondrium, hernia, nodule in the breast, acute mastitis, abdominal pain due to retention of food.
Rhizoma Corydalis: another name has another name called Rhizoma Corydalis, Rhizoma Corydalis, derives from the dry tuber into papaveraceae plant corydalis, has and have promoting blood circulation to remove blood stasis, the function of promoting the circulation of QI pain relieving, cure mainly whole body each portion qi depression to blood stasis pain, dysmenorrhea, amenorrhea, lump in the abdomen, postpartum stagnation, injury from falling down, hernia is had a pain.
Radix Astragali: another name Radix Astragali, Radix Astragali, derive from the root of leguminous plant Radix Astagali or Radix Astragali, have invigorating QI to consolidate the body surface resistance, effect of holder skin ulcer granulation promoting, diuretic, cures mainly the diseases such as deficient qi and blood, spontaneous perspiration, chronic diarrhea proctoptosis, uterine prolapse, nephritis edema, albuminuria, diabetes, chronic ulcer.
Scolopendra: another name Scolopendra, thousand-legger, Gekko Swinhonis, centipede, derive from the dry body of Scolopendridae animal Scolopendpa Subspinipes Mutilans L. KOCH, have endogenous wind stopping spasmolytic, merit poison eliminating stagnation, effect of removing obstruction in the collateral to relieve pain.Cure mainly infantile convulsion, tic spasm, middle air port is askew, hemiplegia, tetanus, rheumatoid arthritis stubborn, skin infection, scrofula, venom.
Hirudo: another name Hirudo, leech, meat awl, derive from the dry body of Hirudinidae animal whitmania, Hirudo or Folium Salicis Babylonicae Hirudo.There is removing blood stasis, removing blood stasis, the effect of stimulating the menstrual flow.Cure mainly lump in the abdomen mass in the abdomen, blood stasis amenorrhea, injury from falling down.
Wear Radix Achyranthis Bidentatae: call sweet Radix Cyathulae, RADIX CYATHULAE, the full Radix Achyranthis Bidentatae in sky, large Radix Achyranthis Bidentatae, Radix Cucubali, turn Radix Achyranthis Bidentatae, imperial Radix Achyranthis Bidentatae, derive from the dry root of amaranthaceous plant Radix Cyathulae, there is eliminating blood stasis and inducing menstruation, easing joint movement, effect of inducing diuresis for treating stranguria syndrome.Cure mainly amenorrhea lump in the abdomen, retention of placenta, arthralgia, flaccidity of the lower limbs clonic spasm of the muscle, hematuria stranguria with blood, injury from falling down.
Rhizoma Chuanxiong: another name rhizome of chuanxiong Qiong, Rhizoma Chuanxiong, derive from the dry rhizome of samphire Rhizoma Chuanxiong.There is blood-activating and qi-promoting, effect of wind-expelling pain-stopping.Cure mainly menoxenia, amenorrhea dysmenorrhea, lump in the abdomen is suffered from abdominal pain, the twinge of the breast side of body, tumbling and swelling, headache, rheumatic arthralgia.
The exempting from of drug use is decocted granule and is unified preparation by Beijing Kang Rentang preparation company limited or other pharmaceuticals and provide, and exempts to decoct bag pack with protection against the tide.
The advantage that the invention has and good effect are: this preparation medicine successful, has no side effect, and exempt from decoction, taking convenience, blood circulation promoting and blood stasis dispelling, effectively and safely can treat chronic prostatitis, to improving the quality of life of patient and preventing recurrence aspect evident in efficacy, be worthy of popularization.
Detailed description of the invention
Below in conjunction with specific embodiment, the invention will be further described.
Embodiment 1 is in 1 part of 1g
A kind of Chinese traditional compound medicine for the treatment of qi stagnation and blood stasis type chronic prostatitis, described Chinese traditional compound medicine, with weight parts, be made up of the crude drug comprising following component: Radix Salviae Miltiorrhizae 20 parts, Semen Vaccariae 15 parts, Radix Paeoniae Rubra 20 parts, 6 parts, Radix Glycyrrhizae, 10 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Corydalis 10 parts, Radix Astragali 20 parts, Scolopendra 3 parts, Hirudo 6 parts, Radix Cyathulae 10 parts, Rhizoma Chuanxiong 12 parts.
Embodiment 2 is in 1 part of 1g
A kind of Chinese traditional compound medicine for the treatment of qi stagnation and blood stasis type chronic prostatitis, described Chinese traditional compound medicine, with weight parts, be made up of the crude drug comprising following component: Radix Salviae Miltiorrhizae 15 parts, Semen Vaccariae 10 parts, Radix Paeoniae Rubra 25 parts, 10 parts, Radix Glycyrrhizae, 5 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Corydalis 15 parts, Radix Astragali 15 parts, Scolopendra 1 part, Hirudo 10 parts, Radix Cyathulae 5 parts, Rhizoma Chuanxiong 15 parts.
Embodiment 3 is in 1 part of 1g
A kind of Chinese traditional compound medicine for the treatment of qi stagnation and blood stasis type chronic prostatitis, described Chinese traditional compound medicine, with weight parts, be made up of the crude drug comprising following component: Radix Salviae Miltiorrhizae 30 parts, Semen Vaccariae 25 parts, Radix Paeoniae Rubra 15 parts, 3 parts, Radix Glycyrrhizae, 15 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Corydalis 5 parts, Radix Astragali 5 parts, Scolopendra 8 parts, Hirudo 15 parts, Radix Cyathulae 20 parts, Rhizoma Chuanxiong 5 parts.
Embodiment 4 is in 1 part of 1g
A kind of Chinese traditional compound medicine for the treatment of qi stagnation and blood stasis type chronic prostatitis, described Chinese traditional compound medicine, with weight parts, be made up of the crude drug comprising following component: Radix Salviae Miltiorrhizae 30 parts, Semen Vaccariae 25 parts, Radix Paeoniae Rubra 15 parts, 3 parts, Radix Glycyrrhizae, 15 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Corydalis 5 parts, Radix Astragali 5 parts, Scolopendra 8 parts, Hirudo 15 parts, Radix Cyathulae 20 parts, Rhizoma Chuanxiong 5 parts, diluent 0.5 part, binding agent 0.1 part.
The above is only preferred embodiment of the present invention, not does any pro forma restriction to technical scheme of the present invention.Every above embodiment is done according to technical spirit of the present invention any simple modification, equivalent variations and modification, all still belong in the scope of technical scheme of the present invention.
Claims (6)
1. treat the Chinese traditional compound medicine of qi stagnation and blood stasis type chronic prostatitis for one kind, it is characterized in that: described Chinese traditional compound medicine, with weight parts, comprise the crude drug of following component: Radix Salviae Miltiorrhizae 10-30 part, Semen Vaccariae 10-25 part, Radix Paeoniae Rubra 15-30 part, Radix Glycyrrhizae 3-15 part, Pericarpium Citri Reticulatae Viride 5-20 part, Rhizoma Corydalis 5-20 part, Radix Astragali 5-30 part, Scolopendra 1-8 part, Hirudo 3-15 part, Radix Cyathulae 5-20 part, Rhizoma Chuanxiong 5-20 part.
2. a kind of Chinese traditional compound medicine for the treatment of qi stagnation and blood stasis type chronic prostatitis according to claim 1, it is characterized in that: described Chinese traditional compound medicine formula, with weight parts, comprises the crude drug of following component: Radix Salviae Miltiorrhizae 20 parts, Semen Vaccariae 15 parts, Radix Paeoniae Rubra 20 parts, 6 parts, Radix Glycyrrhizae, 10 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Corydalis 10 parts, Radix Astragali 20 parts, Scolopendra 3 parts, Hirudo 6 parts, Radix Cyathulae 10 parts, Rhizoma Chuanxiong 12 parts.
3. a kind of Chinese traditional compound medicine for the treatment of qi stagnation and blood stasis type chronic prostatitis according to claim 1, is characterized in that: described herbal mixture dosage form is granule, tablet, pill, powder.
4. a kind of Chinese traditional compound medicine for the treatment of qi stagnation and blood stasis type chronic prostatitis according to claim 1, is characterized in that: described herbal mixture dosage form is granule.
5. a kind of Chinese traditional compound medicine for the treatment of qi stagnation and blood stasis type chronic prostatitis according to claim 1, is characterized in that: described Chinese traditional compound medicine contains edible or pharmaceutic adjuvant.
6. a kind of Chinese traditional compound medicine for the treatment of qi stagnation and blood stasis type chronic prostatitis according to claim 5, is characterized in that: described adjuvant is diluent, suspending agent, antioxidant, emulsifying agent, disintegrating agent, adhesive and antiseptic.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510200623.8A CN104825604A (en) | 2015-04-27 | 2015-04-27 | Compound traditional Chinese medicine preparation for treating qi stagnation and blood stasis type chronic prostatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510200623.8A CN104825604A (en) | 2015-04-27 | 2015-04-27 | Compound traditional Chinese medicine preparation for treating qi stagnation and blood stasis type chronic prostatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104825604A true CN104825604A (en) | 2015-08-12 |
Family
ID=53804055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510200623.8A Pending CN104825604A (en) | 2015-04-27 | 2015-04-27 | Compound traditional Chinese medicine preparation for treating qi stagnation and blood stasis type chronic prostatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104825604A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000095649A (en) * | 1998-09-25 | 2000-04-04 | Alps Yakuhin Kogyo Kk | Testosterone-5alpha-reductase inhibitor |
| CN104095099A (en) * | 2014-06-04 | 2014-10-15 | 胡安然 | Tea for regulating prostatitis |
-
2015
- 2015-04-27 CN CN201510200623.8A patent/CN104825604A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000095649A (en) * | 1998-09-25 | 2000-04-04 | Alps Yakuhin Kogyo Kk | Testosterone-5alpha-reductase inhibitor |
| CN104095099A (en) * | 2014-06-04 | 2014-10-15 | 胡安然 | Tea for regulating prostatitis |
Non-Patent Citations (1)
| Title |
|---|
| 王彬等: "通前络汤治疗60 例慢性前列腺炎随机对照临床研究", 《中国性科学》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102872418B (en) | Medicine for treating pelvic inflammation | |
| CN103705866A (en) | Traditional Chinese medicine composition for treating hypomenorrhea | |
| CN104474371A (en) | Traditional Chinese medicine for treating impotence | |
| CN103156934A (en) | Traditional Chinese medicine for treating apoplexy sequela | |
| CN103721185A (en) | Traditional Chinese medicine for treating spleen-deficiency qi sinking syndrome type gastroptosis disease | |
| CN104958448A (en) | Medicine for treating puerperal infection | |
| CN102416145A (en) | Chinese medicinal composition for treating menstrual disorder | |
| CN103550615B (en) | Traditional Chinese medicine for treating spleen-kidney deficiency scouring disease | |
| CN102784311B (en) | Traditional Chinese medicine composition for curing women's puerperal diseases and preparation method of traditional Chinese medicine composition | |
| CN102772676B (en) | Traditional Chinese medicine for treating empirical vertigo | |
| CN104840891A (en) | Traditional Chinese medicine preparation used for treating alcoholic cardiomyopathy and preparation method thereof | |
| CN101085281A (en) | Traditional Chinese medicine for curing chronic nephritis | |
| CN103536892B (en) | Traditional Chinese medicine for treating infertility of syndrome of yang deficiency and coagulated cold | |
| CN104825604A (en) | Compound traditional Chinese medicine preparation for treating qi stagnation and blood stasis type chronic prostatitis | |
| CN103520570A (en) | Traditional Chinese medicine for treating liver depression forming fire syndrome type acne disease | |
| CN103301405B (en) | Traditional Chinese medicine for treating equine jaundice | |
| CN102670775A (en) | Traditional Chinese medicine for treating non-suppurative costal chondritis | |
| CN103536863B (en) | A kind of Chinese medicine for the treatment of the infertile disease of obstruction of collaterals by blood stasis pattern of syndrome | |
| CN108567926B (en) | Traditional Chinese medicine composition for treating blood stasis collateral blocking type autoimmune hepatitis and preparation method thereof | |
| CN102274358B (en) | Traditional Chinese medicine for treating premature menstruation, profuse menstruation, breast distending pain and large clot quantity | |
| CN105477557A (en) | Decoction drug for treating Qi-blood deficiency and blood stasis type diabetic foot and preparation method | |
| CN103463610B (en) | Traditional Chinese medicine for treating disharmony between ying and wei type muscle impediment disease | |
| CN104800599A (en) | Traditional Chinese medicinal composition for treating deficiency of kidney-yin | |
| CN105616860A (en) | Traditional Chinese medicine recipe for treating coronary heart diseases | |
| CN103550725B (en) | Traditional Chinese medicine for treating rheumatism skin accumulation type hydropsy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150812 |
|
| WD01 | Invention patent application deemed withdrawn after publication |